Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05228171 · ClinicalTrials.gov registry record

Mobile Food Record on Recall Effects

A clinical trial, sponsored by University of Minnesota.

Completed
Registry status
10
Enrollment target

NCT05228171: Completed study, sponsored by University of Minnesota.

NCT05228171 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05228171 has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
10 participants
Enrollment target

Study Summary

Human dietary habits remain challenging to measure. Even the "gold-standard" interviewer-administered 24 hour dietary recall has established underreporting issues especially in high-risk populations, such as patients with obesity. Performance of precision nutrition research requires state of the art tools to capture individual dietary patterns. Given the widespread availability of smart phones, mobile-phone based food records present a prime opportunity to capture "in the field" dietary intake. Mobile food records, however, are not yet widely used in nutrition research. Several reasons exist. First, the mobile food record needs to be validated relative to the "gold standard" of dietary intake, the 24-hour dietary recall. Second, many available mobile food records are commercially based, with caveats about data availability and meeting research-quality data security practices (HIPAA compliance). In response, this study includes using a freely available, research-focused, HIPAA compliant, mobile food record (mCC: my Circadian Clock app) actively used in research studies (including our own ongoing work) to test the hypothesis that a mobile food record can expand capture of dietary intake. The proposed aims include the following: Using a randomized, cross-over design, evaluation of augmenting interviewer-administered 24-hour dietary recalls by a mobile food record (Augmented Recall) results in less energy intake underreporting than a standard (un-augmented) interviewer administered 24-hour dietary recall (Standard Recall).

Primary Outcome

Compare caloric intake assessed by the augmented recall relative to the standardized recall

Interventions

  • BEHAVIORAL mCC app

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2022-03-14
Est. Completion 2023-12-31
University of Minnesota

966 total trials

What the finished NCT05228171 record still lists

NCT05228171 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which mCC app is the first listed.

NCT05228171 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05228171 about?

NCT05228171 is a clinical study titled "Mobile Food Record on Recall Effects". Human dietary habits remain challenging to measure. Even the "gold-standard" interviewer-administered 24 hour dietary recall has established underreporting issues especially in high-risk populations, such as patients with obesity. Performance of precision nutrition research requires state of the art...

What is the current status of trial NCT05228171?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2022-03-14. Estimated completion is 2023-12-31.

What interventions are being tested in trial NCT05228171?

The interventions under investigation include: mCC app (BEHAVIORAL).

Who is sponsoring clinical trial NCT05228171?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05228171, the US trial registry maintained by the National Library of Medicine. NCT05228171 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.